|
|
|
|
|
12.12.25 - 21:01
|
CLS initiates recruitment process for permanent Chief Financial Officer (Cision)
|
|
|
Clinical Laserthermia Systems AB (publ) (“CLS”) today announces that the company has decided to transition from its current interim, part-time consulting CFO arrangement to a permanent and fully employed Chief Financial Officer. The recruitment process for this position has now been initiated.
The decision reflects CLS's ambition to strengthen its financial leadership and establish a more cost efficient, long-term, scalable structure that supports the company's continued growth, operational focus, and international expansion.
“Our business is entering a stage where a full-time CFO is...
|
|
|
12.12.25 - 19:06
|
Rottneros President and CEO Lennart Eberleh has resigned (Cision)
|
|
|
Lennart Eberleh, President and CEO of Rottneros, has resigned to take up another position outside Rottneros, and will leave his position during the first half of 2026. A process to recruit a successor is now underway.
“Lennart has been CEO of Rottneros since 2016 and has done a solid job of developing the Group into the strong position it has today in a number of selected niches in the pulp market, together with an efficient production apparatus,” says Per Lundeen, Chairman of the Board, Rottneros AB.
For further information please contact:
Per Lundeen, Chairman of the Board,...
|
|
|
12.12.25 - 11:30
|
Bulletin from Studsvik AB′s extraordinary general meeting on December 12, 2025 (Cision)
|
|
|
The Extraordinary General Meeting resolved that the Board of Directors shall continue to consist of six members.
It was also decided to elect Anders Bergdahl as a new member of the Board of Directors. The meeting resolved that the new board member shall be remunerated in accordance with the remuneration level decided at the 2025 Annual General Meeting (SEK 236,250), including any committee fees (SEK 50,000), pro rata from the Extraordinary General Meeting until the 2026 Annual General Meeting.
The meeting authorized the Board of Directors, in accordance with the proposal...
|
|
|
12.12.25 - 11:21
|
HennesMauritz AB (HM, H&M) Underperform (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für H&M mit einem Kursziel von 110 schwedischen Kronen auf "Underperform" belassen. Die Verbraucher in fast ganz Europa schienen von einer Wolke der Vorsicht umgeben ......
|
|
|
|
|
12.12.25 - 11:01
|
Diamyd Medical finalizing Phase 3 screening as GMP review progresses (Cision)
|
|
|
The number of randomized participants in DIAGNODE-3, Diamyd Medical's registrational Phase 3 trial in type 1 diabetes, has now exceeded 290, and the screening will conclude in the coming weeks. The interim efficacy analysis of approximately 170 participants with 15-month data is scheduled for end of March 2026. The Company also confirms that its Umeå manufacturing facility is currently under review by the Swedish Medical Products Agency as part of the GMP-certification process.
“Finalizing the screening phase is a major milestone and a significant achievement by all participating clinics in...
|
|
|
|
|
12.12.25 - 10:12
|
Sweden Jobless Rate Falls To 8.2% (AFX)
|
|
|
STOCKHOLM (dpa-AFX) - Sweden's jobless rate decreased in November to the lowest level in four months, figures from Statistics Sweden showed on Friday.The unadjusted unemployment rate decreased to ......
|
|
|
12.12.25 - 10:06
|
Smoltek Marks 20 Years of Nanotechnology Innovation and Looks Ahead to an Era of Scalable Applications (Cision)
|
|
|
This press release is an English version of the previously published Swedish version, which has interpretive precedence.
Smoltek Nanotech Holding AB (publ) (“Smoltek” or “the Company”), a pioneer in vertically aligned nanostructure technology, is celebrating its 20-year anniversary. Since its founding in December 2005, the company has evolved from a research-driven start-up into offering disruptive technologies to global corporations in the semiconductor, electrolysis, and fuel-cell sectors. Now leaving its teens, Smoltek is accelerating the commercialization of its groundbreaking...
|
|
|
12.12.25 - 09:30
|
Svenska Aerogel: Increased demand for Quartzene® in the defense sector (Cision)
|
|
|
Svenska Aerogel Holding AB (publ) (“Svenska Aerogel,” “the Company”) is currently involved in several customer projects within the defense sector focused on “dual-use” products, solutions suitable for both civilian and military applications. These projects represent significant long-term commercial potential.
Svenska Aerogel supplies its aerogel material Quartzene® to multiple dual-use development projects. Quartzene® enhances the thermal insulation of technical and performance textiles and improves both the matte and flame-retardant properties of various types of surface coatings.
In...
|
|
|
|
|
12.12.25 - 09:12
|
Ilham Smaali appointed Chief Supply Chain Officer (PR Newswire)
|
|
|
STOCKHOLM, Dec. 12, 2025 /PRNewswire/ -- The hygiene and health company Essity has appointed Ilham Smaali as Chief Supply Chain Officer. She will take office on December 31, 2025, and will join the company's Executive Management Team. Supply Chain Enablement is a newly established......
|
|
|
|
|
12.12.25 - 08:30
|
Egoo Health powers AI-driven personalized diabetes management in China (Cision)
|
|
|
Qlife Holding AB ("Qlife" or the "Company") is proud to announce that its Egoo Health blood testing platform will play a central role in a groundbreaking project launched by Hipro Biotechnology Co., Ltd. ("Hipro") in collaboration with Beijing Tsinghua Changgung Hospital. The initiative, titled “AI-Assisted Precision Care System for Achieving Synergistic Remission/Reversal of Type 2 Diabetes and MASLD,” aims to transform chronic disease management for millions of patients in China. The project is a performance evaluation study which allows the hospital to use the Egoo HbA1c (3-months average...
|
|
|
|
|
|
|
|
|
12.12.25 - 07:30
|
Tele2 recognized by CDP with an A score for the fourth time (Cision)
|
|
|
Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) today announces that global environmental non-profit CDP has, for the fourth consecutive year, recognized Tele2 for its leadership in corporate transparency and performance on climate change, placing the company on its annual A List.
Based on data reported through CDP's 2025 Climate Change questionnaire, Tele2 is one of the 4% of companies that achieved an A out of a ranking of more than 22,000 companies. CDP's annual environmental disclosure and scoring process is widely recognized as the gold standard in corporate...
|
|
|
|